Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.

J. Eklöf (Copenhagen, Denmark), M. Misiakou (Copenhagen, Denmark), P. Sivapalan (Copenhagen, Denmark), K. Armbruster (Copenhagen, Denmark), A. Browatzki (Copenhagen, Denmark), T. Nielsen (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), H. Andreassen (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark), M. Gabrielaite (Copenhagen, Denmark), H. Johansen (Copenhagen, Denmark), A. Jensen (Copenhagen, Denmark), T. Nielsen (Copenhagen, Denmark), F. Hertz (Copenhagen, Denmark), K. Ghathian (Copenhagen, Denmark), H. Calum (Copenhagen, Denmark), T. Wilcke (Copenhagen, Denmark), N. Seersholm (Copenhagen, Denmark), J. Jensen (Copenhagen, Denmark), R. Marvig (Copenhagen, Denmark)

Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4932
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Eklöf (Copenhagen, Denmark), M. Misiakou (Copenhagen, Denmark), P. Sivapalan (Copenhagen, Denmark), K. Armbruster (Copenhagen, Denmark), A. Browatzki (Copenhagen, Denmark), T. Nielsen (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), H. Andreassen (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark), M. Gabrielaite (Copenhagen, Denmark), H. Johansen (Copenhagen, Denmark), A. Jensen (Copenhagen, Denmark), T. Nielsen (Copenhagen, Denmark), F. Hertz (Copenhagen, Denmark), K. Ghathian (Copenhagen, Denmark), H. Calum (Copenhagen, Denmark), T. Wilcke (Copenhagen, Denmark), N. Seersholm (Copenhagen, Denmark), J. Jensen (Copenhagen, Denmark), R. Marvig (Copenhagen, Denmark). Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.. 4932

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
Source: Eur Respir J 2014; 44: 794-797
Year: 2014


Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?>
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017



Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006



Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001

Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes?
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006

Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis
Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017
Year: 2018



Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021



Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008



Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105
Year: 2006

Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009


Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Newly acquired pseudomonas aeruginosa (P.a.) in Belgian CF-patients: does the patients‘ P.a. genotype correlate with environmental genotypes?
Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems
Year: 2004


Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Pseudomonas aeruginosa colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014